Conditions: Arthritis, Psoriatic
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 17
Healthy volunteers: no

Brief summary:
The primary objective is to evaluate the safety and tolerability of a single intravenous dose of PG102 in patients with psoriatic arthritis. The secondary objectives are to evaluate how PG102 moves around the body and to explore its effects on the disease.

Detailed description:

Arms:
arm 1: Lowest dose PG102 arm 2: Second dose PG102 arm 3: Control

Interventions: intervention 1: PG102 intervention 2: Placebo comparator
Intervention descriptions: intervention 1: A single intravenous infusion intervention 2: Phosphate-buffered saline

Protocol document: